Lithium is recommended as a first line treatment for patients with bipolar disorder. However, only certain patients show a good response to the drug, and the variability and tolerability of lithium response are poorly understood. Greater precision in the early identification of individuals who are likely to respond well to lithium is a significant unmet clinical need. We create optimal designs to better understand the pharmacokinetic exposition of lithium for patients with and without a genetic covariate. From a Fisher information matrix based method, we find different optimal designs for estimating various parameters in a complicated pharmacokinetics/pharmacodynamics nonlinear mixed effects model with multiple physician specified constraints. Our approach uses flexible state-of-the-art metaheuristics to find various types of efficient designs, including multiple-objective optimal designs that can balance the competitiveness of the objectives and deliver higher efficiencies for more important objectives. Results from this article will be used as part of a broader study to implement efficient designs to better understand the exposition of sustained-release lithium in patients with bipolar disorder.
HealdAHHollandDStedmanM, et al.Can we check serum lithium levels less often without compromising patient safety?BJPsych Open2022; 8: e18.
2.
SheikhMQassemMTriantisIF, et al.Advances in therapeutic monitoring of lithium in the management of bipolar disorder. Sensors2022; 22: 736.
3.
YacobiSOrnoyA. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Israel J Psychiat Relat Sci2008; 45: 95.
4.
GitlinM. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord2016; 4: 1–10.
5.
GrofP. Sixty years of lithium responders. Neuropsychobiology2010; 62: 8–16.
6.
GordovezFJAMcMahonFJ. The genetics of bipolar disorder. Mol Psychiat2020; 25: 544–559.
7.
SennerFKohshourMOAbdallaS, et al.The genetics of response to and side effects of lithium treatment in bipolar disorder: future research perspectives. Front Pharmacol2021; 12: 638882.
8.
CouffignalCChevillardLEl BalkhiS, et al.The pharmacokinetics of lithium. In: Malhi GS, Masson M and Bellivier F (eds.) The Science and Practice of Lithium Therapy. Springer International Publishing, 2017. pp.25–53.
9.
CometsEMentréF. Developing tools to evaluate non-linear mixed effect models: 20 years on the npde adventure. AAPS J2021; 23: 75.
10.
NybergJBazzoliCOgungbenroK, et al.Methods and software tools for design evaluation in population pharmacokinetics–pharmacodynamics studies. Br J Clin Pharmacol2015; 79: 6–17.
11.
DumontCLestiniGLe NagardH, et al.PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models. Comput Methods Programs Biomed2018; 156: 217–229.
12.
NelderJMeadR. A simplex method for function minimization. Computer J1965; 1: 308–313.
13.
RetoutSCometsESamsonA, et al.Design in nonlinear mixed effects models: optimization using the Fedorov–Wynn algorithm and power of the Wald test for binary covariates. Stat Med2007; 26: 5162–5179.
14.
DuffullSBRetoutSMentréF. The use of simulated annealing for finding optimal population designs. Comput Methods Programs Biomed2002; 69: 25–35.
15.
WhitacreJM. Recent trends indicate rapid growth of nature-inspired optimization in academia and industry. Computing2011; 93: 121–133.
16.
WhitacreJM. Survival of the flexible: explaining the recent dominance of nature-inspired optimization within a rapidly evolving world. Computing2011; 93: 135–146.
17.
WongWKChenRBHuangCC, et al.A modified particle swarm optimization technique for finding optimal designs for mixture models. PLoSONE2015; 10: e0124720.
18.
XuWWongWKTanKC, et al.Finding high-dimensional D-optimal designs for logistic models via differential evolution. IEEE Access2019; 7: 7133–7146.
WongWKLachenbruchPA. Designing for dose response. Stat Med1996; 15: 343–359.
21.
QiuJChenRBWangW, et al.Using animal instincts to design efficient biomedical studies via particle swarm optimization. Swarm Evol Comput2014; 18: 1–10.
22.
StokesZMandalAWongWK. Using differential evolution to design optimal experiments. Chemometr Intell Lab Syst2020; 199: 103955.
23.
ScheppsMAWongWKAustinM, et al.Optimizing patient recruitment in global clinical trials using nature-inspired metaheuristics. Stat Biopharm Res2024; 17: 87–101.
24.
MalikHIqbalAJoshiP, et al.Metaheuristic and Evolutionary Computation: Algorithms and Applications. Singapore: Springer, 2021.
25.
CouffignalCBertrandJSporticheS, et al.Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder. Eur J Clin Pharmacol2019; 75: 519–528.
26.
BazzoliCRetoutSMentréF. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model. Stat Med2009; 28: 1940–1956.
27.
BauerRJHookerACMentréF. Tutorial for design in NONMEM: clinical trial evaluation and optimization. CPT: Pharmacometrics Sys Pharmacol2021; 10: 1452–1465.
28.
ChernoffH. Sequential Analysis and Optimal Design. Philadelphia: SIAM, 1972.
29.
FedorovV. Theory of Optimal Experiments. New York: Academic Press, 1972.
30.
SilveySD. Optimum Design. London: Chapman and Hall, 1980.
31.
CookRDWongWK. On the equivalence of constrained and compound optimal designs. J Am Stat Assoc1994; 89: 687–692.
32.
ZhuWWongWK. Bayesian optimal designs for estimating a set of symmetric quantiles. Stat Med2001; 20: 123–137.
33.
KonakACoitDWSmithAE. Multi-objective optimization using genetic algorithms: A tutorial. Reliab Eng Syst Safet2006; 91: 992–1007.
TalbiEG. Metaheuristics: from design to implementation. Hoboken: John Wiley & Sons, 2009.
36.
HollandJH. Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence. Cambridge: MIT Press, 1992.
37.
KennedyJEberhartR. Particle swarm optimization. In: Proceedings of ICNN’95 - International Conference on Neural Networks, volume 4. pp.1942–1948.
38.
FranckeT. ppso: particle swarm optimization and dynamically dimensioned search, optionally using parallel computing based on Rmpi, 2020. R package version 0.9-99991, https://www.github.com/TillF/ppso.
39.
BossekJ. ecr 2.0: a modular framework for evolutionary computation in R. In: Proceedings of the Genetic and Evolutionary Computation Conference (GECCO) Companion. GECCO ’18, ACM, pp.1187–1193.
BossekJ. Performance assessment of multi-objective evolutionary algorithms with the R package ecr. In: Proceedings of the Genetic and Evolutionary Computation Conference Companion. GECCO ’18, ACM, pp.1350–1356.
42.
RachmawatiLSrinivasanD. Multiobjective evolutionary algorithm with controllable focus on the knees of the pareto front. IEEE Trans Evol Computation2009; 13: 810–824.
43.
KutnerMHNachtsheimCJNeterJ, et al.Applied linear statistical models. New York: McGraw-Hill, 2005.
44.
PukelsheimF. Optimal design of experiments. Philadelphia: SIAM, 2006.
45.
AtkinsonACBogackaB. Compound D-and D_s-optimum designs for determining the order of a chemical reaction. Technometrics1997; 39: 347–356.
46.
SeuratJNguyenTTMentréF. Robust designs accounting for model uncertainty in longitudinal studies with binary outcomes. Stat Methods Med Res2020; 29: 934–952.
47.
LiQLiuSYYangXS. Influence of initialization on the performance of metaheuristic optimizers. Appl Soft Comput2020; 91: 106193.
48.
DerracJGarcíaSMolinaD, et al.A practical tutorial on the use of nonparametric statistical tests as a methodology for comparing evolutionary and swarm intelligence algorithms. Swarm Evol Comput2011; 1: 3–18.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
